Topical Volumizing Cream Improves Facial Volume and Skin Health in Adults With Rapid Weight Loss From Pharmacologic (GLP‐1/GIP Agonists), Surgical, or Behavioral Interventions
ABSTRACT Background GLP-1 receptor agonists (GLP-1) and dual GLP-1/gastric inhibitory polypeptide (GIP) agonists emerged in recent years to promote weight loss. By reducing subcutaneous fat, collagen, and overall structural support of the skin, rapid weight loss can lead to visual face aging. Aims This study investigates the synergistic effect of a multi-ingredient topical that acts […]
Managing Aesthetic Needs in Prescription Medication‐Driven Rapid Weight Loss Patients: Results of an International Consensus. The Clinician Perspective
ABSTRACT Introduction The global prevalence of obesity has continued to increase at alarming rates. More recently, there has been an exponential increase in the usage of GLP1 agonists in both clinically obese patients and those seeking weight loss. As a result, there has been an influx of patients who are noticing substantial weight loss and […]
The eureka moment that drove Oprah to reframe weight loss and banish shame involved a Post-It
Oprah Winfrey at the American Ballet Theatre Gala on October 22, 2025. Lanna Apisukh/WWD via Getty Images Oprah Winfrey has been a weight-loss icon for decades and has always carried some shame — until now. She recently reframed her own weight loss and now says she’ll be on obesity medication for life. A new book, […]
Ozempic Brings Back The ‘Get A Mac’ Guys As GLP-1 Rivalry Heats Up
Who says pharma can’t have personality? Ozempic leans into humor with a familiar duo, Justin Long and John Hodgman from the ‘Mac VS PC’ era.
Lupin signs licensing pact with Galenicum Health for injectable Semaglutide
Lupin Atlantis Holdings SA (LAHSA) has entered into a partnership with Galenicum for finished formulations of injectable Semaglutide, a GLP-1 receptor agonist
BellRing Brands (BRBR) Climbs 12% on Protein Market Growth, Ahead of Earnings
We recently published 10 Stocks Breaking Records While Wall Street Bleeds. BellRing Brands Inc. (NYSE:BRBR) was one of the top performers on Tuesday. BellRing jumped by 12 percent on Tuesday to close at $26.78 apiece as investors loaded portfolios ahead of its upcoming earnings, supported by optimistic comments about the protein drink industry. According to […]
Novo Nordisk Reteams Apple's Long/Hodgman Ad Duo To Tout Ozempic
Justin Long and John Hodgman this time represent, respectively, Novo Nordisk’s original GLP-1, Ozempic, vs. “other GLP-1 products for type 2 diabetes.”
How Employers Can Save $550/Month on GLP-1s: Introducing Vida Self-Pay
What You Should Know – Vida Health has partnered with RxSaveCard to launch Vida Self-Pay, a first-of-its-kind platform that bypasses traditional PBM markups for anti-obesity medications (AOMs). – By combining virtual, whole-person clinical care with transparent “cash-price” subsidies, the partnership enables employers to save up to $550 per member per month while expanding access to […]
Ozempic’s unexpected side effect: saving airlines $580 million a year on fuel
A new financial report claims weight loss drugs like Ozempic and Wegovy could deliver an unexpected beneficiary: the airline industry. According to a study from investment firm Jefferies, widespread use of GLP-1 medications could reduce average passenger weight enough to meaningfully cut fuel costs, potentially saving major U.S. airlines hundreds of millions of dollars each […]
CoreAge Rx Expands GLP-1 Access to Support New Year Weight Loss Goals
WICHITA FALLS, Texas, Jan. 20, 2026 /PRNewswire/ — CoreAge Rx, a leading telehealth pharmacy specializing in personalized medication services, today announced a strategic New Year’s expansion of its compounded GLP-1 weight management program. The expansion provides increased access to…